China Life Insurance Co. amid a Renewed State‑Backed Market Rally

The day’s market activity was dominated by a coordinated push from China’s largest insurance groups, including China Life Insurance Co., to shore up the A‑share market. The collective stance, announced on 20 July, reaffirmed the insurers’ long‑term confidence in China’s capital markets and signaled a sustained increase in equity exposure across core sectors such as technology, consumer goods and renewable energy.

1. Institutional Endorsement and Capital Allocation

On 20 July, China Life, along with China Insurance Group, Ping An, China Pacific Insurance, and New China Life, publicly declared its unwavering support for the stock market. The communiqué highlighted the insurers’ willingness to deploy long‑term capital, a strategy that aligns with the state’s broader policy of encouraging “patient capital” to stabilize markets during periods of volatility.

  • Asset Base: At the end of 2025, the five insurers collectively held over 20 trillion CNY in assets, a figure that underscores their significant market influence.
  • Equity Investment Growth: The insurers’ equity allocation in the secondary market surged in the latter half of 2025, reflecting a shift towards value‑driven, long‑term investments.

China Life’s recent actions illustrate this trend. Although the company sold 1.1097 million shares of MegaYizhi Innovation (603986.SH) on 8 July—realising approximately 6.8 billion CNY—this divestiture was part of a broader portfolio rebalancing rather than a signal of pessimism. The sale followed a sharp pullback in technology stocks, enabling China Life to capture liquidity while maintaining its strategic stake in high‑growth sectors.

2. Market‑Stabilizing Measures and State‑Backed Liquidity

The state’s intervention on 21 July—announced by the State Development and Investment Corporation (SDIC) and the China Investment Corporation (CIC)—injected more than 50 billion CNY of additional funds through share‑buyback‑supported loans. These injections were aimed at countering the recent tech‑sector sell‑off and preserving market integrity.

  • Impact on Insurance Sector: The influx of liquidity reinforced the insurers’ confidence in the market’s long‑term prospects, encouraging them to increase their equity positions.
  • Broad Market Reaction: The Shanghai Composite rose 0.85 % and the Shenzhen Component fell 0.71 %, while the ChiNext Index gained 0.42 %. The mixed indices reflect sectoral disparities, with technology and consumer stocks benefiting most from the state‑backed support.

3. Forward‑Looking Outlook for China Life

China Life’s current valuation—price‑to‑earnings of 4.73 against a 52‑week high of 47.65 HKD and a low of 20.05 HKD—indicates a relatively modest premium relative to its peers. The company’s robust asset base (market cap of 748 billion HKD) and its commitment to long‑term investing position it well to capitalize on future market upswings.

  • Strategic Focus: China Life is likely to continue allocating capital to high‑growth sectors that align with the state’s priority areas, such as green technology, digital infrastructure, and domestic consumer markets.
  • Risk Management: The recent divestiture of MegaYizhi Innovation shares demonstrates a prudent risk‑management approach, allowing the firm to harvest gains from a volatile tech sector while preserving exposure to other growth opportunities.

In summary, China Life Insurance Co. is navigating a dynamic market environment characterized by state‑backed liquidity injections and a renewed institutional confidence in China’s equity markets. The company’s strategic asset allocation, combined with its long‑term investment philosophy, positions it to benefit from the anticipated market recovery and the continued expansion of high‑growth sectors.